Objective: To analyze the protective effect of Vitamin E on cisplatin toxicity in Sprague Dawley mice nephrons. Material & Methods: This is an experimental study using post-test only control group design, the subject was white male mice (Rattus Norvegicus) adult Sprague Dawley strain (10-12 weeks) of 24 rats divided into four groups. Negative control group (CN) got normal saline 0.9% intraperitoneal 1 cc, Positive control group (CP) got cisplatin 5 mg/kgBB, group P1 got vitamin E 50 mg/kgBB and Cisplatin 5 mg/kgBB, and P2 group got vitamin E 200 mg/kgBB plus cisplatin 5 mg/kgBB intraperitoneal. Cisplatin is conducted in the third week in each treatment group through intraperitoneal injection. Vitamin E is administrated per sonde for the first three weeks resumed on the fourth week to the seventh week. At the end of the seventh week, nephrectomy was performed on the treatment group to analyze the kidney damage. Histopathological observation is performed using a light microscope with a magnification of one hundred and four hundred times magnification. Results: Cisplatin administration resulted in significant tubular and glomerular damage compared to the control group. Increasing the dose of vitamin E in mice that received cisplatin resulted in significant nephron damage compared to the group who received cisplatin alone. Conclusion: Cisplatin administration results in nephrotoxicity in mice. The administration of high dose Vitamin E resulted in increased nephrotoxicity in mice that received cisplatin.
cisplatin, vitamin E, glomelurus, kidney tubules, nephrotoxicity
Hartmann, J.T. Lipp, H.-P. Toxicity of platinum compounds. Expert Opin. Pharmacother; 2003.
Jin Kim, Gi-Su Oh, Ai Hua Shen, Su Bin Lee, Khadka D, Pandit A, Hong-Seob So. Cisplatin induced kidney disfunction and perspectives on improving treatment strategies. The Korean Society of Electrolyte Metabolism. Electrolyte Blood Press. 2004; 12: 55-65.
Brillet G, Deray G, Jacquiaud C et al. Long-term renal effect of cisplatin in man. Am J Nephrol. 1994; 14: 81–84.
Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol. 2003; 23: 460–464.
Siddik, Zahid H.‘Mechanisms of action of cancer chemotherapeutic agents : dna-interactive alkylating agents and antitumour platinum-based drugs’. Snedecor, G., Cochran, W., 1974. Ten Thousand Randomly Assorted Digits, in: Statistical Methods; 2002.
Kawai Y, Nakao T, Kunimura N, et al. relationship of intracellular calcium and oxygen radicals to cisplatin-related renal cell injury. J Pharmacol Sci. 2006; 100: 65-72.
Pabla N, Jiang M, Wei Q et al. Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity. Biochem Pharmacol. 2007; 73: 1499–1510.
Uzunhisarcikli, M., Kalender, Y. Protective effects of vitamins C and E against hepatotoxicity induced by methyl parathion in rats. Ecotoxicol. Environ. Saf. 2011; 74: 2112–2118.
Pace A, Savarese A, Picardo M et al. Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. J Clin Oncol. 2003; 21: 927–931.
Manohar, Sandhya, and Nelson Leung. Cisplatin nephrotoxicity : a review of the lliterature. Journal of Nephrology. 2017; 31(8).
Kunze, Doreen et al. SiRNA-Mediated inhibition of antiapoptotic genes enhances chemotherapy efficacy in bladder cancer cells. 2012; 4318: 4313–18.
Ozkok, Abdullah, and Charles L Edelstein. Pathophysiology of Cisplatin-Induced Acute Kidney Injury; 2014.
Tchounwou, Shaloam dasari; paul bernard. Cisplatin in cancer therapy : Molecular Mechanisms of Action; 2015. p. 364–78.
Volarevic, Vladislav et al. Molecular mechanisms of cisplatin-induced nephrotoxicity : a balance on the knife edge between renoprotection and tumor toxicity. 2019; 9: 1–14.
Pabla N, Dong Z. Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. International Society of Nephrology. Kidney International. 2008; 73: 994–1007.
Miller, Ronald P, Raghu K Tadagavadi, Ganesan Ramesh, and William Brian Reeves. Mechanisms of Cisplatin Nephrotoxicity; 2010. p. 2490–2518.
Darwish, Mostafa A et al. Vitamin E mitigates cisplatin-induced nephrotoxicity due to reversal of oxidative / nitrosative stress , suppression of inflammation and reduction of total renal platinum accumulation; 2016(May): 1–9.
Herrera, E, and C Barbas. Vitamin E : Action, Metabolism and Perspectives. 2001; 57(1): 43–56.
Kontush, Anatol et al. Antioxidant and prooxidant activity of A-Tocopherol in human plasma and low density lipoprotein. 1996; 37: 1436–48.
Tafazoli, Shahrzad, James S Wright, and Peter J O Brien. Prooxidant and antioxidant activity of vitamin E analogues and troglitazone. 2005: 1567–74.
Pearson, Philip et al. The pro-oxidant activity of high-dose vitamin E supplements in vivo. 2006: 20(5); 271–73.
Rizvi, Saliha et al. The role of vitamin E in human health and some disease. 2014(May): 157–65.
Aypar, Umut, William F Morgan, and Janet E Baulch. Mutation research / fundamental and molecular mechanisms of mutagenesis radiation-induced epigenetic alterations after low and high LET irradiations. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 2011; 707(1–2): 24–33.